L26/P-397 Return rates and cumulative live birth rates following the use of oocytes after elective oocyte cryopreservation. 12 years’ experience
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Solé Inarejos und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What are the rates of oocyte utilization and cumulative reproductive outcomes following elective oocyte cryopreservation (EOC) over long-term follow-up? Summary answer Elective oocyte cryopreservation shows increasing utilization over time and high cumulative clinical pregnancy and live birth rates among returning patients. What is known already Oocyte vitrification is a well-established technique with extensive evidence from oocyte donation programs. Increasing postponement of childbearing has led to a growing demand for elective fertility preservation; however, data on long-term utilization patterns and cumulative live birth outcomes after EOC remain limited. Study design, size, duration Retrospective observational study including elective oocyte cryopreservation cycles performed between 2012 and 2024, with follow-up until December 2024. Participants/materials, setting, methods A total of 1,859 women undergoing 2,305 elective oocyte cryopreservation cycles were included. The primary outcome was cumulative live birth rate per patient among those who returned to use their oocytes. Secondary outcomes included oocyte utilization (return) rate, oocyte survival after warming, fertilization rate and usable embryo rate. Descriptive statistics were applied. Main results and the role of chance Between 2012 and December 2024, 1,859 women underwent 2,305 EOC cycles (mean age at vitrification: 35.96 ± 3.09 years), resulting in 20,543 vitrified MII oocytes (mean 11.05 ± 6.34 mature oocytes per cycle). Overall, 18.8% of patients (n = 349) returned to use their vitrified oocytes; this rate increased to 30.2% when considering only cycles performed up to December 2021, highlighting a time-dependent pattern of oocyte utilization. Among returning patients, the mean age at oocyte warming was 40.77 ± 3.17 years, with a mean cryostorage duration of 41.53 months. A total of 3,888 MII oocytes were warmed, with a survival rate of 82.0%. Fertilization and blastocyst formation rates were 73.9% and 42.7%, respectively. Fresh embryo transfer was performed in 44.1% of warming cycles, yielding clinical pregnancy and live birth rates per transfer of 55.0% and 39.5%. No viable embryos were obtained in 12.3% of warming cycles. Up to December 2024, 229 blastocyst warming transfers were performed in 128 patients. Clinical pregnancy and live birth rates per patient were 64.8% and 45.3%, respectively. Among all patients who underwent at least one embryo transfer (n = 198), cumulative clinical pregnancy and live birth rates per patient reached 70.7% and 52.5%. Limitations, reasons for caution The retrospective design and relatively low utilization rate limit direct extrapolation of outcomes to all women undergoing elective oocyte cryopreservation. Wider implications of the findings These findings provide long-term evidence that elective oocyte cryopreservation offers meaningful reproductive potential for women who eventually return to use their oocytes, with utilization rates increasing over time. This information is essential for realistic counselling regarding expectations and long-term reproductive planning. Trial registration number No
Zitieren
APA
Inarejos, M. S., Cruz, C. D. L., Arroyo, G., Parriego, M., Boada, M., Garcia, S., Devesa, M., & Polyzos, N. (2026). L26/P-397 Return rates and cumulative live birth rates following the use of oocytes after elective oocyte cryopreservation. 12 years’ experience. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.731
Vancouver
Inarejos MS, Cruz CDL, Arroyo G, Parriego M, Boada M, Garcia S, et al. L26/P-397 Return rates and cumulative live birth rates following the use of oocytes after elective oocyte cryopreservation. 12 years’ experience. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.731
BibTeX
@article{Inarejos2026,
author = {Inarejos, M. Solé and Cruz, C. De la and Arroyo, G. and Parriego, M. and Boada, M. and Garcia, S. and Devesa, M. and Polyzos, N.P.},
title = {L26/P-397 Return rates and cumulative live birth rates following the use of oocytes after elective oocyte cryopreservation. 12 years’ experience},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.731}
}
EUVIMED